MedTrace Logo

Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine

NCT02901990 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7901

Last updated 2017-06-06

No results posted yet for this study

Summary

This study was aimed to conduct a 3-year perspective study to observe the immunological effect of one-dose mumps-containing vaccine, monitor the incidence of mumps in vaccinated population aged 3-7 years，and provide basis for adjusting MMR immunization strategy in Jiangsu province, China.

Conditions

  • Parotid Gland Infection
  • Fever

Sponsors & Collaborators

  • Jiangsu Province Centers for Disease Control and Prevention

    lead NETWORK

Principal Investigators

  • Fenyang Tang · Jiangsu provincial CDC

Eligibility

Min Age
3 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2017-02-02
Completion
2017-02-02

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02901990 on ClinicalTrials.gov